Soldiers of the Patent Wars
The nature of IP litigation is shifting from using vast armies of review attorneys to SWAT teams of tech experts, explains Animesh Kumar of iRunway.

The nature of IP litigation is shifting from using vast armies of review attorneys to SWAT teams of tech experts, explains Animesh Kumar of iRunway.

Plaintiffs claiming infringement of their products need to structure the claim carefully to avoid dismissal, exlpain Harvey Siskind attorneys.

After a unanimous decision rejecting patentability of laws of nature, without more, innovators may have to turn to other means to protect inventions, explains James DeGraw of Ropes & Gray.

Diligence in discovery can improve defendants' chance of success on summary judgment in copyright actions, says David Tashroudian or Ezra Brutzkus Gubner.

Passage of SOPA, the controversial anti-piracy bill, could result in dire consequences for the tech industry, explains Marc H. Greenberg of Golden Gate University School of Law.

The notorious copyright troll was dealt a blow by several court decisions, but is trying a new strategy to legitimize its suits, explains David Tashroudian of Ezra Brutzkus Gubner.

With courts less inclined to presume it, plaintiffs may need alternative arguments for injunctive relief, explain Sideman & Bancroft attorneys.

America Invents Act will change how patents are issued and reviewed, potentially changing how tech companies do business, explain Schiff Hardin attorneys.

Federal Circuit's holding in 'Classen' invites the Supreme Court to provide clearer guidance on pre-emption, explain Fenwick & West attorneys.

Proper valuation of a debtor's intellectual property portfolio may result in greater value for the estate, debtor and creditors, explains Jonathan Petrus of Pluritas LLC.

By year's end, FDA will release rules controlling the approval process of large molecule generic drugs, explain Duane Morris attorneys.

Federal Circuit held that DNA is patent-eligible subject matter with certain restrictions, but upcoming decisions could provide clarity and narrow the limitations, explain Fenwick & West attorneys.

Thanks to Federal Circuit ruling, alleged infringers will have a harder time dimissing cases based on patentee's inequitable conduct, explains Craig Countryman of Fish & Richardson.

The "willful blindness" standard set by the Supreme Court will be hard to meet absent extreme facts, explains James Batchelder of Ropes & Gray.

Ropes & Gray attorneys update the state of the law and provide tips on defending and pursuing patent infringement claims.

Fast-changing case law can leave an unwary company in an unpredictable scenario, potentially facing enormous damages, explains Robert Andris of Ropers Majeski.

Under proposed copyright laws, designers of affordable alternatives for pricier name brand items could be liable for infringement, says Greenberg Glusker's Lisa Wang.

Recent Ninth Circuit decisions bookend copyright holder's rights, but leave a gap of uncertainty, explains Hiaring & Smith's Vijay Toke.

As 'Myriad' heads to the Federal Circuit, many questions remain unsettled on the patentability of the human genome, explain professors Chester S. Chuang, pictured, and Denys T. Lau.

Ninth Circuit appears to loosen its standard in cases of trademark infringement on certain websites, explains Bruce G. Chapman of Connolly Bove.

Morrison & Foerster attorneys explain the level of scrutiny a non-practicing entity must withstand to bring suit before the commission based on infringing imports.

Scott Hilton of The Focal Point shares five tips for a successful Markman hearing.

Nathaniel Bruno of Sheppard Mullin explores Northern District trends of staying patent infringment suits pending reexamination.
Ropes & Gray's Sasha Rao and Kelly Baxter look at the new state of affairs in the world of technological patents.